GlobeNewswire

Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
11/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to [...]
Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030
11/11/2026
The Company has more than doubled revenue from innovative medicines since launching Pivot to Growth in 2023, demonstrating sustained execution and the growing strength of its high-velocity biopharma model A live webcast [...]
Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering
11/11/2026
Formal collaboration with Dartmouth’s Thayer School of Engineering will advance computationally guided therapeutic protein design supporting Applied Biologics’ gene therapy development programs SCOTTSDALE, Ariz., Nov. [...]
Arvinas to Present at Jefferies Global Healthcare Conference
11/11/2026
NEW HAVEN, Conn., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that [...]
NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage
11/11/2026
A veteran, trained, and certified 17-person sales force, commenced sales operations this week, providing national coverage with customers responsible for approximately 80% of current U.S. ketamine sales Initial supply [...]
Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer
11/11/2026
Physician-scientist and oncology leader brings more than two decades of experience in academic medicine, global clinical development and regulatory submissions BRISBANE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Nurix [...]
Hemab Therapeutics to Participate in Upcoming Investor Conferences
11/11/2026
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood [...]
Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club
11/11/2026
A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access BRECKENRIDGE, Colo., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery , one of the most awarded [...]
Sinaptica Therapeutics to Host Scientific Symposium at CTAD 2026 Exploring the Role of Brain Network Dysfunction in Alzheimer's Disease
11/11/2026
Leading Alzheimer's researchers Giacomo Koch, Emiliano Santarnecchi and Harald Hampel to examine emerging evidence, biomarkers and therapeutic approaches targeting brain network dysfunction Scientific co-founder Giacomo [...]
Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026
11/11/2026
No cases of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS), or graft-versus- [...]
CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo
11/11/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Nov. 11, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that studies have commenced with QIMA Life Sciences, a world leading [...]
AC Immune to Present at Jefferies Global Healthcare Conference 2026
11/11/2026
AC Immune to Present at Jefferies Global Healthcare Conference 2026 Lausanne, Switzerland, November 11, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharma company targeting the key pathologic misfolded [...]
Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease
11/11/2026
Espoo, Finland, 11 November 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, today announces that the Horizon Europe [...]
CHARM Therapeutics and Collaborator Dr. Florian Perner to Present Compelling Data Showing the Potential of Next-Generation Menin Inhibitors to Deliver More Durable Responses for AML at the 8th ASH Annual Meeting
11/11/2026
LONDON – 11 November 2026 -- CHARM Therapeutics (“CHARM”, “The Company”), a clinical-stage biotechnology company addressing resistance in acute myeloid leukemia (AML) with a best-in-class menin inhibitor, today [...]
The savings that cost more: new report puts a number on Europe's innovation choice
11/11/2026
This release is intended for the general public , healthcare professionals, policymakers and other healthcare decision-makers , plus pharmaceutical, policy and trade media. New analysis of five EU countries as well as [...]
Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care
11/11/2026
Bagsværd, Denmark, 11 November 2026 – Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027–2036. Announced ahead of World Diabetes Day (14 November), the funding will [...]
Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management
11/11/2026
After a year of building with manufacturing and quality teams, Devia spins out of Visium and is now available to the world’s largest biopharma companies, CDMOs and CROs, so every deviation gets solved once, not closed [...]
Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London
11/11/2026
Leiden, the Netherlands, November 11, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the 2026 Jefferies Global Healthcare Conference in London, United Kingdom, on November [...]
Onco-Innovations Announces Agreement to Terminate Performance-Based Funding Arrangement with Sorbie
11/11/2026
VANCOUVER, British Columbia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Onco-Innovations Limited (CBOE: ONCO ) (“ Onco ” or the “ Company ”) announces that it has entered into a termination agreement (the “ Termination Agreement [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum